Navigation Links
WuXi PharmaTech Announces Third-Quarter 2010 Results
Date:11/9/2010

p>

34,415Accounts payable

16,065

14,356Accrued expenses

21,671

17,072Deferred revenue

7,192

4,554Advanced subsidies

2,630

2,800Other taxes payable

4,331

2,901Other current liabilities

6,609

4,239   Total current liabilities64,758

80,337Non-current liabilities:Long-term debt, excluding current portion

1,919

2,115Advanced subsidies

1,288

1,420Convertible notes

35,864

35,864Other non-current liabilities

6,567

7,432   Total non-current liabilities45,638

46,831   Total liabilities110,396

127,168Equity:Ordinary shares ($0.02 par value, 5,002,550,000 authorized as of September 30, 2010 and December 31, 2009, respectively; 559,232,416 and 550,609,256 issued and outstanding as of September 30, 2010 and December 31, 2009, respectively)

11,185

11,012Additional paid-in capital

329,193

320,672Accumulated earnings (deficit)

4,904

(68,631)Accumulated other comprehensive income

22,479

17,080   Total equity367,761

280,133 Total liabilities and equity478,157

407,301WUXI PHARMATECH (CAYMAN) INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands of U.S. dollars, except ADS data and per ADS data)Three Months EndedSeptember 30, Nine Months Ended September 30, 2010 2009 % Change 2010 2009% ChangeNet revenues:Laboratory Services

76,761

64,284

19%

216,340

182,369

19%Manufacturing Services

7,086

5,757

23%

29,146

13,774

112%Total net revenues83,847

70,041

20%

245,486

196,143

25%Cost of revenues:Laboratory Services

(48,152)

(36,731)

31%

(128,608)

(105,790)

22%Manufacturing Services

(5,865)

(4,540)

29%

(23,423)'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
2. WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
3. Professor Steven V. Ley Speaks at WuXi PharmaTech
4. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
5. WuXi PharmaTech Announces Second-Quarter 2010 Results
6. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
7. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
8. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
9. WuXi PharmaTech Announces First-Quarter 2010 Results
10. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
11. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 The Physician-Patient Alliance for Health ... 28, 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance ... Safety." A sentence was omitted from ... "PPAHS is a member of the National Coalition ... information on the National Coalition to Promote Continuous Monitoring ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... Ore., July 31, 2015  Semler Scientific, Inc. (Nasdaq: ... testing services to healthcare insurers and physician groups, today ... 30, 2015. "In the second quarter ... year revenue growth of 54%, quarter over quarter revenue ... the installed base of FloChec® units of 18%," said ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
(Date:7/31/2015)... , ... July 31, 2015 , ... ... the RenovoCath,™ a novel catheter that was developed for targeted delivery of fluids ... are now being treated at Florida Hospital Tampa with the device that provides ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Patients with higher ... to a study published today in Nature Communications and led by researchers from the ... suggests that variations in the gene RTN1 led to greater production of the related ...
(Date:7/31/2015)... ... July 31, 2015 , ... Awarded to only the Top 10 hair transplant ... they are the latest recipients of the Center of Clinical Excellence for ARTAS ... worldwide leaders in the science of hair transplant. , Parsa Mohebi Hair Restoration is ...
(Date:7/31/2015)... NB (PRWEB) , ... July 31, 2015 , ... Indosoft, ... script builder in Q-Suite 5.9. Q-Suite is their flagship contact center ACD system ... that the agent script display logic shows the script components to the agent only ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... release a newly redesigned website at Healthpointe.net. The new website will feature a ... , The redesign serves to provide smoother interactions between patients and the Healthpointe ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Healthpointe Announces Newly Redesigned Website 2
... a technique to attack and destroy tumours without causing ... hair loss. ,They have used nanotechnology to ... leave healthy tissue unaffected. ,The particles - ... they zero in on their target. ,Traditional ...
... A chemical emergency struck Salisbury, suburb north of the Adelaide ... a five-year-old kid , sliding down in a popular ... ,It is not clear what happened to the ... out something had gone wrong. ,Health authorities described ...
... out of care do not live as long as those ... Medicine and Veterans Affairs researchers in a report published ... available on line. ,"In an era when highly ... causes AIDS) is keeping people alive, understanding the value of ...
... Britain have developed an artificial plastic blood, which they claim ... be a huge advantage in war zones. ... that have an iron atom at their core, like haemoglobin, ... researchers say they were looking for extra funding to develop ...
... for a Tasmanian school was convicted to a four-month jail ... and making pornography out of it. ,Adrian Alan ... indecency, one count of producing child exploitation material, and one ... used the school's own camera to take 36 pictures of ...
... To help people understand who is at risk for the disease, ... up some common myths about osteoporosis. ,1. MYTH: ... many more women who may develop this condition, theres also a ... In fact, roughly 2 million men suffer from osteoporosis, accounting for ...
Cached Medicine News:Health News:New Cancer Therapy That can Be Less Painful 2Health News:Children Using Slide in Playground Treated for Exposure to Poisoning 2Health News:HIV Survival Improves If Patients Stay in Care 2Health News:7 Common Myths About Osteoporosis 2Health News:7 Common Myths About Osteoporosis 3
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
... with the MAMMOTOME® HH (Hand ... invasive procedure using ultrasound imaging ... images to locate breast abnormalities, ... and map the area you ...
... Provides reliable strength for temporary wound ... which compliant and stretchable support material ... transudate is not required. Predictable absorption. ... be inert, nonantigenic, and nonpyrogenic. ,VICRYL ...
... Mesh plugs perform best when the ... contact with a smooth wall of highly ... means less tissue remodeling to help stabilize ... fills more of the defect with gentle ...
Medicine Products: